Reports for PRO DOC LIMITEE
Company Name
PRO DOC LIMITEE
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 7 (2%) | |
| Resolved: | 329 (95%) | |
Discontinuation Reports |
149 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 144 (97%) | |
| Reversed: | 4 (3%) | |
Late reports |
16 (3%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUVOXAMINE-50 | 50MG | TABLET | Resolved | 2019-01-23 | 2019-01-31 | 73323 |
| FLUVOXAMINE-50 | 50MG | TABLET | Resolved | 2017-10-16 | 2018-03-14 | 26046 |
| FOSINOPRIL-20 | 20MG | TABLET | Resolved | 2017-12-05 | 2017-12-15 | 31799 |
| PRO-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-11-14 | 2018-12-12 | 66906 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-03-17 | 2023-07-11 | 108855 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-06-29 | 2018-01-05 | 14330 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-09-07 | 2018-01-17 | 21233 |
| GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-10-12 | 2018-01-11 | 25684 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-02 | 2023-07-11 | 83018 |
| GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-06 | 2023-07-11 | 90894 |
| GLICLAZIDE-80 | 80MG | TABLET | Resolved | 2020-06-08 | 2021-03-19 | 116856 |
| GLYBURIDE | 2.5MG | TABLET | Resolved | 2019-01-14 | 2019-05-28 | 72084 |
| HYDROCHLOROTHIAZIDE TAB 25MG | 25MG | TABLET | Resolved | 2018-07-27 | 2018-08-01 | 56848 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-08-07 | 2020-08-20 | 121934 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2019-08-15 | 2019-08-24 | 91651 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-02-20 | 2020-03-05 | 106777 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-12-10 | 2020-12-17 | 129949 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-05-23 | 2019-11-23 | 84606 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-12 | 2019-04-24 | 81528 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2019-05-23 | 2019-06-19 | 84603 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
| RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
| TEMAZEPAM-15 | 15MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9551 |
| TEMAZEPAM-30 | 30MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9554 |
| TERAZOSIN-2 | 2MG | TABLET | Discontinued | 2021-06-25 | 2021-08-12 | 141500 |
| TERAZOSIN-5 | 5MG | TABLET | Discontinued | 2021-06-25 | 2021-07-28 | 141503 |
| TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2019-07-24 | 2019-09-12 | 89923 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2021-04-07 | 2021-04-08 | 137050 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-02 | 2021-04-03 | 136790 |